$NKGEN BIOTECH (NKGN.US)$
NKGen Biotech's Positive Phase 1 Clinical Data in Moderate Alzheimer's Disease Advances Troculeucel into Phase 2 with First Patient Dosed in Phase 1/2a Trial
Two of the first three patients in the Phase 1 cohort of the Phase 1/2a clinical trial, treated at the highest dose of 6 billion cells per treatment, were found to have improved CDR-SB cognitive scores, resulting in a clinical upgrade from moderate AD to mild AD after only three months on therapy.
First patient...

$Lumen Technologies (LUMN.US)$
going to try for $6 again?

$Workhorse (WKHS.US)$ 👈folks, over 90% of the shares are being traded in public. that means retail can control the price. shorties needs to reverse the play and join the bulls. stop trying to beat everything down to 0.00. $Faraday Future Intelligent Electric Inc. (FFIE.US)$ $Nikola (NKLA.US)$

$Ocean Power Technologies (OPTT.US)$
Ocean Power Technologies Awarded $1M Contract for Naval Information Warfare Center Pacific’s Project Overmatch’ Mission Autonomy Proving Grounds
Ocean Power Technologies (NYSE American: OPTT) has been awarded a $1M follow-on contract as a subcontractor to EpiSci for the Naval Information Warfare Center Pacific's Project Overmatch' Mission Autonomy Proving Grounds. This comes after a successful 12-month demonstration of OPT's autonomous surface vehicle tech...

$Ocean Power Technologies (OPTT.US)$ Ocean Power Technologies Awarded $1M Follow-On Contract As Subcontractor To EpiSci After Successful Demonstration Of Autonomous Surface Vehicle Technologies In Project Overmatch
Benzinga· 2 mins ago